Cost and Utilization Outcomes in Huntsman at Home, a Novel Oncology Hospital at Home Program

J Am Med Dir Assoc. 2024 Apr;25(4):610-613. doi: 10.1016/j.jamda.2023.06.030. Epub 2023 Aug 1.

Abstract

Objectives: In a real-world trial, we previously demonstrated that Huntsman at Home, a novel oncology hospital at home program, was associated with reduced health care utilization and costs. In this study, we sought to understand the impact of Huntsman at Home in specific patient subgroups defined by sex, age, area-level median income, Charlson Comorbidity Index, and current use of systemic anticancer therapy.

Design: Retrospective case-control study of the Huntsman Cancer Institute. Electronic Data Warehouse of patients enrolled in Huntsman at Home between August 2018 through October 2019 vs usual-care patients.

Setting and participants: A total of 169 patients admitted to Huntsman at Home compared with 198 usual-care patients.

Methods: Five dichotomous subgroups evaluated including sex (female vs male), age (≥65 vs <65), income (≥$78,735 vs <$78,735), Charlson Comorbidity Index (≥2 vs <2), and current systemic anticancer therapy use vs no current systemic anticancer therapy. Groups were compared with patients receiving usual care. Primary outcomes included 30-day costs, hospital length of stay, unplanned hospitalizations, and emergency room visits.

Results: Admission to Huntsman at Home was associated with an overall reduction across all 4 health care cost and utilization outcomes. Outcomes favoring admission to Huntsman at Home achieved statistical significance (P < .05) in at least 2 of the 4 outcomes for each subgroup studied. Of the subgroups that did not achieve statistically significant benefit from Huntsman at Home admission in some outcome categories, none of these subgroups favored usual care.

Conclusions and implications: Admission to Huntsman at Home decreased utilization of unplanned health care and reduced costs across a wide spectrum of patient subgroups, suggesting overall consistent benefit from the service. Hospital at home models should be considered as a means by which the quality and efficiency of care can be maximized for patients with cancer.

Keywords: Hospital at home; cost outcomes; oncology; utilization outcomes.

MeSH terms

  • Aged
  • Case-Control Studies
  • Female
  • Health Care Costs*
  • Hospitalization*
  • Hospitals
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies